COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.43% | -53.43% | 145.48% | -34.09% | -34.09% |
| Total Receivables | 105.39% | 503.57% | 752.07% | 38.69% | 38.69% |
| Inventory | -40.39% | 3,735.94% | -32.88% | 3,184.95% | 3,184.95% |
| Prepaid Expenses | 47,625.00% | 11.27% | 1,998.77% | -99.85% | -99.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -33.64% | -- | 247.37% | -- | -- |
| Total Current Assets | -50.30% | -34.75% | 112.84% | -27.64% | -27.64% |
|
|
|||||
| Total Current Assets | -50.30% | -34.75% | 112.84% | -27.64% | -27.64% |
| Net Property, Plant & Equipment | -5.01% | 3,833.21% | -5.83% | 4,239.25% | 4,239.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -100.00% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -93.41% | -60.74% | -85.11% | 516.31% | 516.31% |
| Total Assets | -44.93% | -2.05% | 47.69% | 7.66% | 7.66% |
|
|
|||||
| Total Accounts Payable | -57.18% | 18.90% | 756.58% | -- | -- |
| Total Accrued Expenses | -32.00% | -0.52% | 224.35% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -48.65% | 64.29% | -9.36% | 180.69% | 180.69% |
| Total Finance Division Other Current Liabilities | -36.99% | 161.43% | -- | -7.17% | -7.17% |
| Total Other Current Liabilities | -36.99% | 161.43% | -- | -7.17% | -7.17% |
| Total Current Liabilities | -43.65% | 34.41% | 450.88% | 142.78% | 142.78% |
|
|
|||||
| Total Current Liabilities | -43.65% | 34.41% | 450.88% | 142.78% | 142.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 60.08% | 2,366.25% | 45.75% | 1,405.88% | 1,405.88% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.53% | -11.30% | -- | -4.55% | -4.55% |
| Total Liabilities | -14.09% | 11.56% | 708.45% | 36.85% | 36.85% |
|
|
|||||
| Common Stock & APIC | 2.72% | -92.33% | 66.35% | -92.50% | -92.50% |
| Retained Earnings | -1,223.74% | 96.09% | -378.01% | 100.43% | 100.43% |
| Treasury Stock & Other | -35.96% | -97.58% | -11.92% | -97.15% | -97.15% |
| Total Common Equity | -72.94% | -21.79% | -37.43% | -9.81% | -9.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -72.94% | -21.79% | -37.43% | -9.81% | -9.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -72.94% | -21.79% | -37.43% | -9.81% | -9.81% |
|
|
|||||